[Form 4] CIM REAL ESTATE FINANCE TRUST, INC. Insider Trading Activity

Rhea-AI Filing Summary

Thomas Patrick Duncan, an independent director of CIM Real Estate Finance Trust, Inc. (CMRF), was granted 19,157.088 shares of restricted common stock on 10/01/2025 as part of the issuer's annual director retainer under the 2022 Equity Incentive Plan. The award was granted at a price of $0 and will vest on 10/01/2026. After the grant, Mr. Duncan beneficially owned 79,964.801 shares. The Form 4 was filed by one reporting person and signed by an attorney-in-fact on 10/01/2025. The filing documents a routine equity-based director compensation award with a one-year vesting schedule and specifies the total shares held following the transaction.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Duncan Thomas Patrick

(Last) (First) (Middle)

2398 EAST CAMELBACK ROAD, 4TH FLOOR

(Street)

PHOENIX AZ 85016

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
CIM REAL ESTATE FINANCE TRUST, INC. [ NONE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
10/01/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	10/01/2025		A		19,157.088(1)	A	$0	79,964.801	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. On October 1, 2025, as part of the annual retainers paid to the Issuer's independent directors and pursuant to the Issuer's 2022 Equity Incentive Plan, Mr. Duncan was granted 19,157.088 shares of the Issuer's restricted common stock. The shares of restricted common stock will vest on October 1, 2026.

Remarks:

	/s/ Laura Eichelsderfer, as Attorney-in-fact	10/01/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did the Form 4 for CMRF filed by Thomas Patrick Duncan report?

The Form 4 reported a grant of 19,157.088 restricted common shares to Thomas Patrick Duncan on 10/01/2025 under the 2022 Equity Incentive Plan.

When do the restricted shares granted to the CMRF director vest?

The restricted shares vest on 10/01/2026.

How many CMRF shares did the reporting person beneficially own after the transaction?

Following the reported transaction, the reporting person beneficially owned 79,964.801 shares.

What was the reported price for the restricted shares in the Form 4?

The reported price for the restricted shares was $0.

Who signed the Form 4 filing for CMRF and when?

The Form 4 was signed by Laura Eichelsderfer, as Attorney-in-fact on 10/01/2025.